Hipertrofično nedonošče
DOI:
https://doi.org/10.5457/ams.v47iSup%201.424Keywords:
hypertrophic newborn, premature infant, macrosomia, gestational diabetes mellitusAbstract
Hypertrophy or excessive fetal growth denotes infant with birth weight greater than ninety percentile for gestational age or term newborns with birth weight greater than 4000 grams. In the overall perinatal population hypertrophic newborns accounts for about 10%, while the incidence of hypertrophic premature infants is 1.09%.The etiology of newbors hypertrophyis multifactorial. Risk factors are genetic predisposition, maternal age over30 years, male gender, diabetes of mothers, infants with Beckwith-Wiedemann syndrome, fetal erythroblastosis, transposition of the great arteries and others. During vaginal delivery of hypertrophic newborns there is a greater risk for complications for the mother and the newborn like shoulder dystocia in the birth canal and brachial plexus injury and increased risk of bleeding after childbirth and disruption of soft parts of maternity channel.Perinatal morbidity ofhypertrophic newborns is twice higher compared toeutrophic newborns mostly because birth trauma or hypoglycemia which usually occurs 1-2 hours after birth due to fetal hyperinsulinemia present.In the hypertrophicinfantsperinatal asphyxia, caesarean section, meconium aspiration, hypocalcemia,hyperbilirubinemia, respiratory distress syndrome, dystocia shoulder are more common. The negative consequences of increased fetal growth are not limited only to the perinatal period. Compared with normal birth weight infants, hypertrophic newborns have increasedrisk of obesity, coronary heart disease, hypertension and diabetes mellitus type 2 in adolescence and adulthood.The aim is to highlight the importance of a multidisciplinary approach of gynecologist, anesthetist and neonatologist in providing of hypertrophy newborns in rder to reduce the morbidity and mortality of mothers and newborns.
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
